# Altimmune, Inc. (ALT) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$94M |
| 2024 | -$103M |
| 2023 | -$96M |
| 2022 | -$88M |
| 2021 | -$97M |
| 2020 | -$55M |
| 2019 | -$21M |
| 2018 | -$43M |
| 2017 | -$52M |
| 2016 | -$11M |
| 2011 | -$12M |
| 2010 | -$24M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | -$21M |
| 2025-06-30 | -$23M |
| 2025-03-31 | -$22M |
| 2024-09-30 | -$25M |
| 2024-06-30 | -$27M |
| 2024-03-31 | -$27M |
| 2023-09-30 | -$23M |
| 2023-06-30 | -$18M |
| 2023-03-31 | -$22M |
| 2022-09-30 | -$25M |
| 2022-06-30 | -$20M |
| 2022-03-31 | -$19M |
| 2021-09-30 | -$33M |
| 2021-06-30 | -$25M |
| 2021-03-31 | -$15M |
| 2020-09-30 | -$18M |
| 2020-06-30 | -$18M |
| 2020-03-31 | -$7M |
| 2019-09-30 | -$11M |
| 2019-06-30 | -$4M |
| 2019-03-31 | -$2M |
| 2018-09-30 | -$4M |
| 2018-06-30 | -$5M |
| 2018-03-31 | -$6M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALT/operating-income)